HOME > Investor Relations > Management policy > Disclosure Policy

Management policy

Disclosure Policy

Basic Policy

TRANS GENIC strives to disclose information promptly based on transparency, fairness, continuity and timeliness for the purpose of building a relationship of trust with all of our stakeholders, including shareholders and investors.

Methods of Disclosure

Information that falls within the scope of the Timely Disclosure Regulations stipulated by the Securities and Exchange Law and the Tokyo Stock Exchange is made public on the Timely Disclosure Network (TDnet) provided by the Tokyo Stock Exchange.
Following the disclosure, TRANS GENIC also provides the same information promptly to news organizations, and releases the information by publishing it on this website.

Forward-looking Statements

Statements in this website, other than statements of historical fact, are forward-looking statements made by TRANS GENIC based on information available at the time of making the prediction. Please note that actual results and performance may vary from the statements as a result of various risks, uncertainties and other factors.

Silent Period

In order to prevent leaks of information on financial results and ensure fairness, TRANS GENIC has established a “silent period” from the day following the date of settlement until the announcement of the results. During the silent period, TRANS GENIC refrains from making any comment or responding to questions on its financial results. However, in the event that results are expected to substantially differ from forecasts, TRANS GENIC will make appropriate announcements in accordance with the Timely Disclosure Regulations.

Management policy

To Our Shareholders
To Our Shareholders

Message to investors from CEO.

Corporate Governance
Corporate Governance

TransGenic's corporate governance.

Business-Related and Other Risks
Business-Related and Other Risks

TransGenic's business-related and other risks.

Disclosure Policy
Disclosure Policy

TransGenic's disclosure policy.

  • Press Releases
Contact Us/Products&ServicesE-mail
  • Reproductive Technology Training
Back to Top